06.05.2024
Prevent & Delay
$827,337.00
36 months
From Benign Islet Autoimmunity to Type 1 Diabetes: HLA-A- vs. HLA-B-restricted CD8+ T-Cell Biomarkers of Progression
Funds will support a project aimed at developing an assay capable of detecting T1D autoimmunity.